U.S. Medical Equipment Stock News

Conagra Brands (CAG) just reported third quarter results that topped revenue expectations but narrowly missed earnings per share forecasts, while also tightening 2026 guidance and highlighting ongoing pressure from input costs and softer margins. See our latest analysis for Conagra Brands. The latest results land against a weak share price backdrop, with a 30 day share price return of 17.09% and a 1 year total shareholder return loss of 36.88%, which points to fading longer term momentum...

If you are wondering whether Ventas at around US$83.27 offers fair value or a potential mismatch between price and fundamentals, this article walks through the key signals to watch. The stock has returned 0.7% over the last 7 days, 7.7% year to date and 22.9% over the past year, alongside a 3 year return of 115.3% and a 5 year return of 79.6%, which raises questions about how much optimism is already in the price. Recent coverage has focused on Ventas as a major health care REIT, with...

Over the past week, Lam Research has been in the spotlight as investors, analysts and funds highlighted its strong AI-driven semiconductor equipment demand, recent fiscal Q2 2026 outperformance, and deepening role in high-bandwidth memory and advanced packaging supply chains. At the same time, contrasting analyst views on margin risks, geopolitical supply concerns, and an increased stake from Ray Dalio’s Bridgewater are creating a more complex picture of Lam’s risk‑reward balance. Next,...

Wondering whether Allegion's current share price reflects its true worth, or if the market is mispricing the stock right now. The shares closed at US$141.06, with returns of a 3.2% decline over 7 days, a 10.9% decline over 30 days, and a 12.3% decline year to date, set against a 12.4% gain over the past year and 47.9% over 3 years. Recent coverage has focused on Allegion as a steady building products business, with investors watching how its security and access solutions fit into long term...

Lattice Semiconductor recently reported a past quarter in which revenue exceeded analyst expectations, inventories improved, and management pointed to strong contributions from AI and data center demand. The company’s recognition for post-quantum cybersecurity FPGAs and a reinforced role alongside AI infrastructure providers highlights how it is tying its low-power chips to some of the most security-sensitive and fast-growing computing workloads. With these results underscoring accelerating...

AbCellera Biologics recently outlined its evolution toward becoming a mid- to late-stage biotech at the 2026 KeyBanc Capital Markets Healthcare Forum, highlighting a clinical pipeline that includes ABCL635 in Phase 2 for non-hormonal hot flashes and ABCL575 in Phase 1 for immunological diseases. The company also underscored a cash position of roughly US$700 million and a three-year funding runway, a combination that may give it unusual flexibility to keep advancing its programs and...

Recent share performance in context McDonald's (MCD) has seen its share price under some pressure recently, with a 7.5% decline over the past month, while the past 3 months show a modest 1.3% gain. See our latest analysis for McDonald's. Set against a 1-year total shareholder return decline of 1.3% and a 5-year total shareholder return of 49.4%, McDonald's recent 1-month share price return decline of 7.5% suggests momentum has cooled after a stronger multi year run. If recent moves in...

Shareholders appeared unconcerned with Utah Medical Products, Inc.'s ( NASDAQ:UTMD ) lackluster earnings report last...

Following the solid earnings report from Macy's, Inc. ( NYSE:M ), the market responded by bidding up the stock price...

Mobileye Global (MBLY) recently announced that a major U.S. automaker plans to integrate its Driver Monitoring System with the EyeQ6L chip across future vehicle models, a large production program targeting millions of cars beginning in 2027. See our latest analysis for Mobileye Global. Despite securing this large production win, Mobileye Global’s 7 day share price return of 9.24% comes after a 90 day share price decline of 33.66% and a 1 year total shareholder return decline of 47.76%. This...

Kohl’s recently reported fourth-quarter 2025 results that beat earnings expectations, outlined early benefits from tighter inventory and supply chain planning, and confirmed that its Sephora at Kohl’s partnership is expanding with more prestige brands and a long-term goal of building a US$2.00 billion beauty business. Together, these updates suggest Kohl’s is leaning heavily on beauty and operational discipline to refresh its relevance in an increasingly competitive retail landscape. Next,...

Goldman Sachs recently reaffirmed its Sell rating on Lazard, signaling continued concern about the firm's financial advisory and asset management prospects. This renewed negative stance highlights how influential analyst opinions can shape perceptions of Lazard’s business outlook and risk profile. Next, we’ll examine how Goldman Sachs’ reiterated Sell rating might influence Lazard’s existing investment narrative and expectations around its expansion plans. AI is about to change healthcare...

Revvity (RVTY) is drawing attention after recent trading left the stock with a return of about 1.2% over the past day, while performance over the past 3 months remains weaker. See our latest analysis for Revvity. At a share price of $88.94, Revvity’s recent 1.2% daily and 2.1% 7 day share price returns contrast with a weaker 30 day share price return of 7.3% and a 1 year total shareholder return decline of 11.5%, suggesting momentum has been fading over a longer horizon as investors reassess...

Recently, Zacks upgraded Otter Tail to a Rank #2 (Buy) after analysts revised their earnings forecasts higher, signaling a more favorable outlook for the company’s future profits. This shift in analyst expectations highlights how changes in projected earnings alone, without new operational announcements, can meaningfully influence market perceptions of Otter Tail. We’ll now examine how this earnings-driven analyst upgrade interacts with concerns about regulation, capital costs, and long-term...

Recently, analysts raised their earnings and revenue estimates for PagSeguro Digital, and the company received a favorable Zacks Rank #2 (Buy) alongside strong value ratings based on metrics such as P/E, PEG, P/S, and P/CF. This combination of improved analyst expectations and indications that PagSeguro may be undervalued versus peers highlights a widening gap between current pricing and perceived fundamentals. With analysts pointing to PagSeguro’s attractive value metrics, we’ll now assess...

In late March 2026, Robinhood Markets, Inc. announced a US$1.50 billion open-ended Class A share repurchase program expected to run over about three years, while also highlighting strong March equity and options trading activity alongside softer crypto volumes and expanding banking deposits. At the same time, questions about Robinhood’s role in the upcoming SpaceX IPO, pressure on crypto trading, and new legal battles over prediction markets have sharpened the focus on how durable its...

In recent days, multiple law firms, including The Schall Law Firm and The Rosen Law Firm, began investigating PennyMac Financial Services over potential securities law violations after the company reported a sharp drop in servicing segment pretax income. At the same time, KBRA assigned preliminary ratings to 58 classes of mortgage-backed certificates backed by loans originated and serviced by PennyMac Loan Services, highlighting the company’s continued role in the non-owner-occupied and...

In March 2026, Customers Bancorp reported quarterly results with year-on-year revenue growth above analyst forecasts and a small earnings per share beat. Ahead of these results, board member Robert N. Mackay disclosed plans to retire after the 2026 Annual Meeting to focus on his external CEO role, with no disagreements cited over the bank’s operations or policies. We’ll now examine how this earnings outperformance shapes Customers Bancorp’s investment narrative, particularly in relation to...

If you are wondering whether Wintrust Financial at around US$139.60 is still good value or if the easy gains are behind it, this article walks through the key valuation checks so you can judge the price for yourself. The stock has returned 3.2% over the last 7 days, while the 30-day and year-to-date returns sit at a 3.9% decline and a 2.1% decline, set against a 41.9% return over 1 year, 107.2% over 3 years and 99.6% over 5 years. Recent coverage has focused on Wintrust Financial's position...

Valaris (VAL) has been in focus after reporting quarterly revenue and EBITDA above consensus, with management pointing to operational excellence and high revenue efficiency as key drivers behind the results. See our latest analysis for Valaris. At a share price of $98.04, Valaris has seen a 1-month share price return of 8.18% and a 3-month share price return of 88.00%. Its 1-year total shareholder return of 184.17% reflects strong recent momentum after the latest earnings beat. If the recent...

Sigma Lithium (NasdaqCM: SGML) has secured offtake prepayments totaling $146 million from customers. The company has obtained a $100 million collateralized bank guarantee, fully backed by its customers. These arrangements support working capital and the construction of a second plant expected to double production capacity. The funding structure allows Sigma Lithium to move ahead without raising additional equity. Sigma Lithium, a producer focused on sustainable lithium supply, is tightening...

TransDigm Group (TDG) is back in focus after fiscal Q1 results exceeded analyst expectations, full year revenue guidance was raised, and management paired fresh acquisitions with share buybacks and comments about the stock’s valuation. See our latest analysis for TransDigm Group. Despite the recent Q1 beat and higher guidance, the share price has pulled back, with a 30 day share price return of 12.0% and a year to date share price return of a 14.1% decline. At the same time, the 3 year total...

Wondering whether Construction Partners is still fairly priced after its strong run, or if the current level is already baking in too much optimism. The stock last closed at US$105.89, with a 1 year return of 48.5% and a very large 3 year gain, although the past 30 days included a 21.7% pullback and year to date the return sits at a 5.6% decline. Recent coverage has focused on Construction Partners as a US road construction specialist, with investors paying close attention to contract...

Bitmine Immersion Technologies recently launched MAVAN, an institutional-grade, largely U.S.-based Ethereum staking platform, and rapidly expanded staking of its 4.73 million ETH treasury, with more than 3.14 million ETH now generating recurring rewards. By controlling about 3.92% of all ETH and operating its own institutional staking infrastructure, Bitmine is positioning itself as a core infrastructure provider for Ethereum-based yield and validation services rather than a simple corporate...